Shanghai Nianxing Industrial Co., Ltd
China
Product Name: ACT 178882
Price: Check
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

DC Chemicals Limited
China
Product Name: Mk-1597
Price: ￥Inquiry/100mg ￥Inquiry/250mg ￥Inquiry/1g
Purity: 98.0%
Stocking Period: 10 Day
Contact: Tony Cao
Email: sales@dcchemicals.com

1007392-69-9

1007392-69-9 structure

1007392-69-9 structure

Name: ACT 178882
Chemical Name: ACT 178882
CAS Number: 1007392-69-9
Molecular Formula: C₃₃H₃₈Cl₃N₃O₄
Molecular Weight: 647.031
Catalog: Signaling Pathways Metabolic Enzyme/Protease Renin
Create Date: 2018-01-10 08:31:19
Modify Date: 2024-02-26 19:53:25
ACT 178882 is a new Renin inhibitor with an IC50 of 1.4 nM.

Name	ACT 178882
Synonyms	(3R,4S)-N-[2-Chloro-5-(2-methoxyethyl)benzyl]-N-cyclopropyl-4-{6-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]-3-pyridinyl}-3-piperidinecarboxamide 3-Piperidinecarboxamide, N-[[2-chloro-5-(2-methoxyethyl)phenyl]methyl]-N-cyclopropyl-4-[6-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]-3-pyridinyl]-, (3R,4S)-

Description	ACT 178882 is a new Renin inhibitor with an IC50 of 1.4 nM.
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> Renin Research Areas >> Metabolic Disease
Target	IC50: 1.4 nM (Renin)[1]
In Vitro	The median time to Cmax (tmax) for ACT 178882 is prolonged from 3.5 to 5.0 h by diltiazem whereas its apparent terminal half-life (t½) is unaffected by diltiazem, 22.9 and 24.2 h for treatments A and B, respectively. Using treatment A as reference, the geometric mean ratio (90% CI) is 1.62 (1.36 to 1.94) for Cmax and 2.02 (1.75 to 2.34) for AUC∞, indicating a significant interaction between ACT 178882 and diltiazem[2].
Cell Assay	Venous blood samples for the determination of ACT 178882 are drawn at the following time points: pre-dose and 1, 2, 3, 4, 5, 6, 8, 12, 16, 24, 36, 48, 72, 96 and 120 h after dosing with ACT 178882 in treatment A and pre-dose and 1, 2, 3, 4, 5, 6, 8, 12, 16, 24, 36, 48, 72, 96, 120, 144, 168, 192, 216 and 240 h after dosing with ACT178882 in treatment B. For diltiazem as soon as possible after collection, and for ACT-178882 within maximally 30 minutes after collection, the tubes are centrifuged and the plasma separated. All samples are stored in an upright position at -20 °C (ACT 178882) or -80 °C (diltiazem) or below pending analysis[2].
References	[1]. Corminboeuf O, et al. Piperidine-based renin inhibitors: upper chain optimization. Bioorg Med Chem Lett. 2010 Nov 1;20(21):6291-6. [2]. Dingemanse J, et al. Drug-drug interaction study of ACT-178882, a new renin inhibitor, and diltiazem in healthy subjects. Clin Drug Investig. 2013 Mar;33(3):207-13.

Density	1.3±0.1 g/cm3
Boiling Point	764.3±60.0 °C at 760 mmHg
Molecular Formula	C₃₃H₃₈Cl₃N₃O₄
Molecular Weight	647.031
Flash Point	416.0±32.9 °C
Exact Mass	645.192810
LogP	6.12
Vapour Pressure	0.0±2.6 mmHg at 25°C
Index of Refraction	1.623

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.